Skip to Content

Afluria Approval History

  • FDA approved: Yes (First approved September 28th, 2007)
  • Brand name: Afluria
  • Generic name: influenza virus vaccine
  • Dosage form: Injection
  • Company: CSL Biotherapies
  • Treatment for: Influenza Prophylaxis

Afluria (influenza virus vaccine) is an inactivated influenza virus vaccine, indicated for active immunization against influenza disease.

Development History and FDA Approval Process for Afluria

Sep 14, 2017Approval Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Aug 29, 2016Approval Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
Sep 28, 2007Approval CSL Biotherapies Announces FDA Marketing Approval of Afluria

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.